Core Viewpoint - AbbVie is considered an attractive investment opportunity due to its strong dividend yield and growth potential in the pharmaceutical sector [4]. Group 1: Investment Considerations - To receive 212 per share, totaling an investment of 6.56 per share, which has been increasing annually, suggesting potential for future income growth [3]. - Diversification is recommended, as investing heavily in a single stock like AbbVie may expose investors to higher risk [3]. Group 2: Company Overview - AbbVie, spun off from Abbott Laboratories in 2013, has a market value of approximately $380 billion and operates in various therapeutic areas including immunology, oncology, aesthetics, neuroscience, and eye care [4]. - The company has recently entered the weight loss drug market, which has generated excitement among investors, alongside its attractive dividend yield of 3.1% that has grown at an average annual rate of 7% over the past five years [5]. - Concerns exist regarding the potential income loss from the expiration of patent protections for major drugs like Humira, although AbbVie has new drugs that are performing well in the market [5].
Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends